Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

ZOM Zomedica Corp

-0.0024 (-1.54%)
Jun 14 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 2,365,552
Bid Price
Ask Price
News -
Day High 0.1559


52 Week Range


Day Low 0.1501
Company Name Stock Ticker Symbol Market Type
Zomedica Corp ZOM AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0024 -1.54% 0.1532 19:43:52
Open Price Low Price High Price Close Price Prev Close
0.1545 0.1501 0.1559 0.151 0.1556
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,927 2,365,552 $ 0.1534994 $ 363,111 - 0.12 - 0.245
Last Trade Time Type Quantity Stock Price Currency
20:00:00 2,166 $ 0.151 USD

Zomedica Corp Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
265.99M 949.95M - 25.19M -34.53M -0.04 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Zomedica News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ZOM Message Board. Create One! See More Posts on ZOM Message Board See More Message Board Posts

Historical ZOM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.15340.15690.1470.15124443,878,330-0.0002-0.13%
1 Month0.19090.1930.1470.16669684,499,496-0.0377-19.75%
3 Months0.13730.19520.12230.15447835,561,3360.015911.58%
6 Months0.16420.22850.120.15521285,774,434-0.011-6.70%
1 Year0.19720.2450.120.16803754,695,134-0.044-22.31%
3 Years0.9450.97980.120.370979711,651,449-0.7918-83.79%
5 Years0.26012.910.06280.712515425,414,980-0.1069-41.10%

Zomedica Description

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.

Your Recent History

Delayed Upgrade Clock